Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022
Illumina (NASDAQ: ILMN) will release its third quarter 2022 financial results on November 3, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (NASDAQ: ILMN) will release its third quarter 2022 financial results on November 3, 2022, after market close. The conference call for discussion will occur at 2:00 PM PT (5:00 PM ET) on the same day, hosted by CEO Francis deSouza and Interim CFO Joydeep Goswami. Investors can access the call via Illumina's investor website or by phone. A replay will be available for at least 30 days post-event. Illumina continues to lead in DNA sequencing and array-based technologies, supporting various health science applications.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was -3.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, Chief Executive Officer, and Joydeep Goswami, Chief Strategy and Corporate Development Officer and Interim Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, November 3, 2022. Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.409.1555 or +1.313.209.4906 outside North America, both with Conference ID 7679670. To ensure timely connection, please dial in at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Sarah Shew
+1.858.336.3157
sshew@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-third-quarter-2022-financial-results-on-thursday-november-3-2022-301641961.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.